ILMN · NASDAQ
ILMN · NASDAQ
236.94 USD
-53.12 (-18.31%)
Illumina fell a further 14.11% on unusually heavy volume as investors focused on Q3 revenue of $1.13 billion, below the $1.15 billion estimate, and management's limited visibility into 2027 AI-related revenue after the October 30 results. source The Nasdaq also fell 2.49% and volatility rose, adding pressure to the stock, while TXG fell 2.48% and PACB rose 2.47%. The selloff extended the earlier post-earnings reaction, with no new catalyst behind the larger move.
Illumina fell a further 14.11% on unusually heavy volume as investors focused on Q3 revenue of $1.13 billion, below the $1.15 billion estimate, and management's limited visibility into 2027 AI-related revenue after the October 30 results. source The Nasdaq also fell 2.49% and volatility rose, adding pressure to the stock, while TXG fell 2.48% and PACB rose 2.47%. The selloff extended the earlier post-earnings reaction, with no new catalyst behind the larger move.